Endothelial nitric oxide synthase gene polymorphisms and the shedding of circulating tumour cells in the blood of prostate cancer patients

Cancer Letters

Volumn 189, Issue 1, 2003, Pages 85-90

  Medeiros, Rui ^a   Morais, Antonio ^a   Vasconcelos, André ^a   Costa, Sandra ^a   Carrilho, Susana ^a   Oliveira, Jorge ^a   Lopes, Carlos ^a  

^a PORTUGUESE ONCOLOGY INSTITUTE   (Portugal)

Author keywords

Micrometastization; Nitric oxide synthases; Polymorphism; Prostate cancer; Prostate specific membrane antigen; Reverse transcription polymerase chain reaction

Indexed keywords

ASPARTIC ACID; GLUTAMINE; NITRIC OXIDE SYNTHASE; PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ALLELE; ARTICLE; CANCER DIAGNOSIS; CANCER SURVIVAL; CONTROLLED STUDY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; METASTASIS; OUTCOMES RESEARCH; PRIORITY JOURNAL; PROSTATE CARCINOMA; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR CELL;

AGED; ENDOTHELIUM, VASCULAR; GENE FREQUENCY; GENOTYPE; HUMANS; MALE; MIDDLE AGED; NEOPLASM CIRCULATING CELLS; NEOPLASM METASTASIS; NITRIC OXIDE SYNTHASE; POLYMORPHISM, GENETIC; PROSTATIC NEOPLASMS;

EID: 0037427566     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(02)00118-0     Document Type: Article

References (42)

1. Murata J., Tada M., R M., Iggo D., Sawamura Y., Shinohe Y., Abe H. Nitric oxide as a carcinogen: analysis by yeast functional assay of inactivating p53 mutations induced by nitric oxide. Mutat. Res. 379:1997;211-218.
2. Forstermann U., J P., Boissel H. Expressional control of the 'constitutive' isoforms of nitric oxide synthase (NOS I and NOS III). FASEB J. 12:1998;773-790.
3. Gradini R., Realacci M., Ginepri A., Naso G., Santangelo C., Sale O.P., Berardi A., Petrangeli E., Gallucci M., Di Silverio F., Russo M.A. Nitric oxide synthases in normal and benign hyperplastic human prostate: immunohistochemistry and molecular biology. J. Pathol. 189:1999;224-229.
4. Hayek O.R., Shabsigh A., Kaplan S.A., Kiss A.J., Chen M.W., Burchardt T., Burchardt M., Olsson C.A., Buttyan R. Castration induces acute vasoconstriction of blood vessels in the rat prostate concomitant with a reduction of prostatic nitric oxide synthase activity. J. Urol. 162:1999;1527-1531.
5. Klotz T., Mathers M.J., Bloch W., Nayal W., Engelmann U. Nitric oxide based influence of nitrates on micturition in patients with benign prostatic hyperplasia. Int. Urol. Nephrol. 31:1999;335-341.
6. Grande M., Carlstrom K., Stege R., Pousette A., Faxen M. Estrogens increase the endothelial nitric oxide synthase (ecNOS) mRNA level in LNCaP human prostate carcinoma cells. Prostate. 45:2000;232-237.
7. Qian J., Jenkins R.B., Bostwick D.G. Genetic and chromosomal alterations in prostatic intraepithelial neoplasia and carcinoma detected by fluorescence in situ hybridization. Eur. Urol. 35:1999;479-483.
8. Nihei N., Ohta S., Kuramochi H., Kugoh H., Oshimura M., Barrett J.C., Isaacs J.T., Igarashi T., Ito H., Masai M., Ichikawa Y., Ichikawa T. Metastasis suppressor gene(s) for rat prostate cancer on the long arm of human chromosome 7. Genes Chromosomes Cancer. 24:1999;1-8.
9. Karashima T., Taguchi T., Yoshikawa C., Kamada M., Kasahara K., Yuri K., Shuin T. Numerical chromosomal changes in metastatic prostate cancer following anti-androgen therapy: fluorescence in situ hybridization analysis of five Japanese cases. Cancer Genet. Cytogenet. 120:2000;148-154.
10. Moreno J., Croce C., Fischer R., Monne M., Vihko P., Mulholland S., Gomella L. Detection of hematogenous micrometatasis in patients with prostate cancer. Cancer Res. 52:1992;6110-6112.
11. Ghossein R.A., Carusone L., Bhattacharya S. Polymerase chain reaction detection of micrometastases and circulating tumor cells: application to melanoma, prostate and thyroid carcinomas. Diag. Mol. Pathol. 8:1999;165-175.
12. Pantel K., Cote R.J., Fodstad O. Detection and clinical importance of micrometastatic disease. J. Natl. Cancer Inst. 91:1999;113-1124.
13. Dong Z., Staroselsky A.H., Zi X., Xie K., Fidler I.J. Inverse correlation between expression of inducible nitric oxide synthase activity and production of metastasis in K-1735 murine melanoma cells. Cancer Res. 54:1994;789-793.
14. Tsukada T., Yokoyama K., Arai T., Takemoto F., Hara S., Yamada A., Kawaguchi Y., Hosoya T., Igaris J. Evidence of association of the ecNOS gene polymorphism with plasma NO metabolite levels in humans. Biochem. Biophys. Res. Commun. 245:1998;190-193.
15. Hibi K., Ishigami T., Tamura K., Mizushima S., Nyui N., Fujita T., Ochiai H., Kosuge M., Watanabe Y., Yoshii Y., Kihara M., Kimura K., Ishii M., Umemura S. Endothelial nitric oxide synthase gene polymorphism and acute myocardial infarction. Hypertension. 32:1999;521-526.
16. Wang X.L., Sim A.S., Badenhop R.F., McCredie R.M., Wilcken D.E. A smoking-dependent risk of coronary artery disease associated with a polymorphism of the endothelial nitric oxide synthase gene. Nat. Med. 2:1996;41-45.
17. Miller A.S., Dykes D.D., Polesky H.F. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 16:1988;1215.
18. Chomczynski P., Sachi N. Single step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:1987;156-159.
19. Israeli R., Miller W., Sai S., Powell T., Fair W., Samadi D., Huryk R., DeBlasio A., Edwards E., Wise G., Heston W. Sensitive nested reverse transcription polymerase chain reaction detection of circulating prostatic tumor cells: comparison of prostate-specific membrane antigen and prostate-specific antigen-based assays. Cancer Res. 54:1994;6306-6310.
20. Klotz T., Bloch W., Volberg C., Engelmann U., Addicks K. Selective expression of inducible nitric oxide synthase in human prostate carcinoma. Cancer. 82:1998;1897-1903.
21. Chamness S.L., Ricker D., Crone J.K., M C.L., Maguire P., Burnett A.L., Chang T.S. The effect of androgen on nitric oxide synthase in the male reproductive tract of the rat. Fertil. Steril. 63:1995;1101-1107.
22. Fidler I.J. Metastasis: quantitative analysis of distribution and fate of tumor emboli labelled with 125 I-5-iodod-2-deoxyuridine. J. Natl. Cancer Inst. 45:1970;773-775.
23. Glaves D. Correlation between circulation cancer cells and incidence of metastases. Br. J. Cancer. 48:1983;665-668.
24. Weiss L. Biomechanical interactions of cancer cells with the microvasculature during hematogenous metastasis. Cancer Metastasis Rev. 11:1992;227-230.
25. Sato H., Suzuki M. Deformability and viability of tumor cells by transcapillary passage with reference to organ affinity in metastasis in cancer. Weiss L., Fundamental Aspects of Metastasis. 1976;311-315 North-Holland, Amsterdam.
26. Fidler I.J. The relationship of embolic homogeneity, number, size and viability to the incidence of experimental metastasis. Eur. J. Cancer. 9:1973;223-228.
27. Liotta L.A., Kleinerman J., Saidel G.M. The significance of hematogenous tumor cell clumps in the metastasis process. Cancer Res. 36:1976;889-893.
28. Karpatkin S., Pearlstein E., Ambrogio C., Coller B.S. Role of adhesive proteins in platelet tumor interaction in vitro and metastasis formation in vivo. J. Clin. Invest. 81:1988;1012-1018.
29. Gorelik E. Augmentation of the antimetastatic effect of anticoagulant drugs by immunostimulation in mice. Cancer Res. 47:1987;809-814.
30. Herberman R.B. Natural killer cells. Prog. Clin. Biol. Res. 288:1989;161-166.
31. Fidler I.J. Macrophages and metastasis: a biological approach to cancer therapy: presidential address. Cancer Res. 45:1985;4714-4719.
32. Tanaka N.G., Tohgo A., Ogawa H. Platelet-aggregating activities of metastasising tumor cells. V. In situ roles of platelets in hematogenous metastases. Invasion Metastasis. 1986;209-216.
33. Tsuruo T., Kawabata H., Iida H., Yomori T. Tumor-induced platelet aggregation and growth promoting factors as determinants for successful metastasis. Clin. Exp. Metastasis. 7:1986;25-30.
34. Li L., Nicolson G.L., Fidler I.J. Direct in vitro lysis of metastatic tumor cells by cytokine-activated murine vascular endothelial cells. Cancer Res. 51:1991;245-254.
35. Li L., Kilbourn R.G., Adams J., Fidler I.J. Role of nitric oxide in lysis of tumor cells by citokine activated-activated endothelial cells. Cancer Res. 51:1991;2531-2535.
36. Nathan C. Nitric oxide as a secretory product of mammalian cells. FASEB J. 6:1992;3051-3056.
37. Stuehr D.J., Nathan C.F. Nitric oxide, a macrophage product responsible for cytostasis and respiratory inhibition of tumor target cells. J. Exp. Med. 169:1989;1543-1548.
38. Hibbs J.B., Taintor R.R., Vavrin Z. Macrophage cytotoxicity: role for L-arginine deiminase activity and amino nitrogen to nitrate. Science. 235:1987;473-478.
39. Salvucci O., Carsana M., Bersani I., Tragni G., Anichini A. Antiapoptotic role of endogenous nitric oxide in human melanoma cells. Cancer Res. 61:2001;318-326.
40. Wang B., Xiong Q., Shi Q., Le X., Abbruzzese J.L., Xie K. Intact nitric oxide synthase II gene is required for interferon-beta-mediated suppression of growth and metastasis of pancreatic adenocarcinoma. Cancer Res. 61:2001;71-75.
41. Wang B., Xiong Q., Shi Q., Tan D., Lee X., Xie K. Genetic disruption of host nitric oxide synthase II gene impairs melanoma-induced angiogenesis and suppresses pleural effusion. Int. J. Cancer. 91:2001;607-611.
42. Wang H.H., McIntosh A.R., Hasinoff B.B., Rector E.S., Ahmed N., Nance D.M., Orr F.W. B16 melanoma cell arrest in the mouse liver induces nitric oxide release and sinusoidal cytotoxicity: a natural hepatic defense against metastasis. Cancer Res. 60:2000;5862-5869.